title: Downregulation of human CD46 by adenovirus serotype 35 vectors.
abstract: Human CD46 (membrane cofactor protein), which serves as a receptor for a variety of pathogens, including strains of measles virus, human herpesvirus type 6 and Neisseria, is rapidly downregulated from the cell surface following infection by these pathogens. Here, we report that replication-incompetent adenovirus (Ad) serotype 35 (Ad35) vectors, which belong to subgroup B and recognize human CD46 as a receptor, downregulate CD46 following infection. A decline in the surface expression of CD46 in human peripheral blood mononuclear cells was detectable 6 h after infection, and reached maximum (72%) 12 h after infection. Ad35 vector-induced downregulation of surface CD46 levels gradually recovered after the removal of Ad35 vectors, however, complete recovery of CD46 expression was not observed even at 96 h after removal. The surface expression of CD46 was also reduced after incubation with fiber-substituted Ad serotype 5 (Ad5) vectors bearing Ad35 fiber proteins, ultraviolet-irradiated Ad35, vectors and recombinant Ad35 fiber knob proteins; in contrast, conventional Ad5 vectors did not induce surface CD46 downregulation, suggesting that the fiber knob protein of Ad35 plays a crucial role in the downregulation of surface CD46 density. These results have important implications for gene therapy using CD46-utilizing Ad vectors and for the pathogenesis of Ads that interact with CD46.
authors: Laboratory of Gene Transfer and Regulation, National Institute of Biomedical Innovation, Osaka, Japan.
authors: F
authors: F
authors: Sakurai
authors: K
authors: K
authors: Akitomo
authors: K
authors: K
authors: Kawabata
authors: T
authors: T
authors: Hayakawa
authors: H
authors: H
authors: Mizuguchi
mesh_terms: D000257:Adenoviridae Infections / Q000276:immunology*; D000260:Adenoviruses, Human / Q000235:genetics / Q000276:immunology*; D015153:Blotting, Western; D045744:Cell Line, Tumor; D015536:Down-Regulation; D005434:Flow Cytometry; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000009:adverse effects* / Q000379:methods; D005822:Genetic Vectors / Q000009:adverse effects* / Q000235:genetics; D049452:Green Fluorescent Proteins / Q000235:genetics; D006801:Humans; D008156:Luciferases / Q000235:genetics; D051916:Membrane Cofactor Protein / Q000032:analysis / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D051916:Membrane Cofactor Protein; D049452:Green Fluorescent Proteins; D008156:Luciferases